Although GLP-1RA prescription was not significantly associated with a reduced risk, it demonstrated a favorable trend (HR, 0.65; 95% CI: 0.37–1.14).
← all excerpts
GLP-1 receptor agonists and acute diabetes complications in adults with type 1 diabetes.
1
—
—